Skip to search formSkip to main contentSkip to account menu

Butaclamol

Known as: Butaclamol [Chemical/Ingredient] 
A benzocycloheptapyridoisoquinolinol that has been used as an antipsychotic, especially in schizophrenia.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
The pKa values for butaclamol (1), 1,2,3,5,6,10b beta-hexahydro-6 alpha-phenylpyrrolo[2,1-alpha]isoquinoline (2, McN-4612-Y), and… 
1984
1984
The semirigid 7-phenylquinolizidine system was selected for the design of new potential antipsychotic agents because it fulfills… 
1981
1981
Summary We characterized the properties of vascular dopamine receptors on isolated rabbit mesenteric arteries preincubated with… 
1979
1979
Several analogues of the neuroleptic agent butaclamol, having modifications in the ring E region of the molecule, have been… 
1979
1979
Several analogues of the neuroleptic agent butaclamol having modifications in the rings A/B region of the molecule have been… 
1978
1978
The synthesis of analogues of the antipsychotic drug butaclamol bearing chloro substituents on the benzene rings is described. On… 
1978
1978
Prompted by an interest in the similarity of brain and tuberoinfundibular systems, the authors studied butaclamol-specific… 
1978
1978
The synthesis and some pharmacological effects of 16 3-aryl analogues of butaclamol, a new antipsychotic drug, are described. The… 
1978
1978
This study examined the possible involvement of dopamine (DA) in mediating the inhibition of episodic LH release that occurs… 
1976
1976
The 3-isopropyl (I), 3-cyclohexyl (II) and 3-phenyl (III) analogs of the new antipsychotic drug butaclamol, which contains a 3…